Shares of DexCom (DXCM) declined 10% on Friday after investment firm Hunterbrook Capital disclosed a short position in the ...

The North American precision nutrition market offers significant growth opportunities driven by U.S. dominance, burgeoning ...

Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. DexCom, Inc. is one of them.

Your device's unique device identifier and model number are on the back of your receiver. Some of Dexcom's continuous glucose monitoring receivers have been recalled due to speaker malfunctions, which ...

Fintel reports that on October 1, 2025, Goldman Sachs maintained coverage of DexCom (NasdaqGS:DXCM) with a Buy recommendation ...

DexCom (DXCM) stock declines after a short report, yet analysts from TD Cowen and Baird stay bullish on the company's prospects. Read more here.

More details about a possible deal in the media industry contributed to another leg up for Paramount and Warner Bros ...

The retail tie-up, RxSmartSaver, could help customers access GoodRx savings services for branded treatments at nearly 2,200 ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $99.3, a high estimate of $106.00, and a low estimate of $89.00. Marking an ...